| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 7, 2020 | NBIX Neurocrine Biosciences Inc | Bozigian Haig P. | Chief Development Officer | Sell | 1,623 | $103.33 | $167,701.67 | -1.1% | |
| Feb 7, 2020 | NBIX Neurocrine Biosciences Inc | Abernethy Matt57 | Chief Financial Officer | Sell | 2,030 | $103.35 | $209,806.59 | -26.3% | |
| Feb 7, 2020 | NBIX Neurocrine Biosciences Inc | Cooke Julie59 | Chief Human Resources Officer | Sell | 913 | $103.26 | $94,276.20 | -16.4% | |
| Feb 7, 2020 | NBIX Neurocrine Biosciences Inc | Gano Kyle54 | Chief Business Development Off | Sell | 1,623 | $103.33 | $167,710.27 | -1.7% | |
| Feb 7, 2020 | NBIX Neurocrine Biosciences Inc | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 1,218 | $103.31 | $125,832.55 | -1.1% | |
| Feb 7, 2020 | PCRX Pacira Biosciences, Inc. | Riker Lauren Bullaro76 | Vice President, Finance | Sell | 1,000 | $46.81 | $46,810.00 | -4.6% | |
| Feb 7, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Shandell Jason B. | President And General Counsel | Sell | 44,401 | $19.75 | $876,765.02 | -9.6% | |
| Feb 6, 2020 | CVSI Cv Sciences, Inc. | Maroon Joseph C Md | Director | Buy | 26,000 | $0.94 | $24,440.00 | +3.6% | |
| Feb 6, 2020 | NBIX Neurocrine Biosciences Inc | Bozigian Haig P. | Chief Development Officer | Sell | 3,441 | $102.43 | $352,448.97 | -0.8% | |
| Feb 6, 2020 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Executive Chairman | Sell | 60,000 | $60.90 | $3,654,088.16 | -2.1% | |
| Feb 6, 2020 | NBIX Neurocrine Biosciences Inc | Gano Kyle54 | Chief Business Development Off | Sell | 4,690 | $102.70 | $481,674.98 | -1.3% | |
| Feb 6, 2020 | NBIX Neurocrine Biosciences Inc | Lloyd-Smith Malcolm49 | Chief Regulatory Officer | Sell | 3,438 | $102.38 | $351,990.78 | -5.1% | |
| Feb 6, 2020 | NBIX Neurocrine Biosciences Inc | Gorman Kevin Charles55 | Chief Executive Officer | Sell | 9,792 | $102.41 | $1,002,793.48 | -0.8% | |
| Feb 6, 2020 | NBIX Neurocrine Biosciences Inc | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 2,421 | $102.58 | $248,350.51 | -0.7% | |
| Feb 6, 2020 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 2,948 | $102.36 | $301,762.67 | -4.3% | |
| Feb 6, 2020 | NBIX Neurocrine Biosciences Inc | Benevich Eric62 | Chief Commercial Officer | Sell | 3,349 | $102.38 | $342,872.07 | -6.1% | |
| Feb 5, 2020 | NBIX Neurocrine Biosciences Inc | Cooke Julie59 | Chief Human Resources Officer | Sell | 605 | $103.17 | $62,417.31 | -13.7% | |
| Feb 5, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 200,000 | $146.61 | $29,321,807.87 | - | |
| Feb 3, 2020 | TXMD Therapeuticsmd, Inc. | Krassan Mitchell | Chief Strategy Officer | Sell | 300,000 | $2.26 | $676,920.00 | -100% | |
| Feb 3, 2020 | ZTS Zoetis Inc. | Chen Heidi C.47 | Executive Vice President | Sell | 1,179 | $134.58 | $158,669.82 | -9.3% | |
| Feb 3, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $19.12 | $9,558.30 | -0.7% | |
| Jan 31, 2020 | IRWD Ironwood Pharmaceuticals Inc | Gilbert Halley E | Chief Admin Officer &SVP | Sell | 60,000 | $12.05 | $723,000.00 | -17.6% | |
| Jan 30, 2020 | JNJ Johnson & Johnson | Sneed Michael E | EVP, Global Corp Aff &COO | Sell | 58,128 | $149.39 | $8,683,567.54 | -54.1% | |
| Jan 29, 2020 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 26,000 | $0.32 | $8,273.50 | - | |
| Jan 27, 2020 | YCBD Cbdmd, Inc. | Elliott Mark S | CFO &COO | Buy | 5,000 | $1.06 | $5,300.00 | +10.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.